3 rezilta yo
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety.
TECHNICAL FIELD
The present invention
TECHNOLOGICAL FIELD OF THE INVENTION
This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof.
TECHNOLOGICAL BACKGROUND OF THE INVENTION
Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two
TECHNOLOGICAL FIELD OF THE INVENTION
This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof.
TECHNOLOGICAL BACKGROUND OF THE INVENTION
Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two